Skip to content

A clinical study to see the effect of some Ayurvedic formulation in the treatment of far sightedness.

RANDOMIZED CONTROLLED CLINICAL TRIAL ON COMBINATION OF BHASKAR GHRITA NASYA AND SAPTAMRITA LAUHA IN MANAGEMENT OF PRATHAMA-DWITIYA PATALGATA TIMIR w.r.t HYPERMETROPIA

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/12/038889
Enrollment
56
Registered
2021-12-23
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H520- Hypermetropia

Interventions

None listed

Sponsors

Sane Guruji Arogya Kendra
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients having symptoms of Prathama Dwitiya Patalgata Timir will be included. 2. Patients who have = +5 D in both the eyes 3. The patient age from 18 years to 60 years of age 4. Patient having vision of 6/9 or less i.e., 6/12, 6/18,6/24, 6/36, 6/60. 5. Patient yogya for Nasya Karma. 6. Patient of either gender will be included in the study.

Exclusion criteria

Exclusion criteria: 1. Patients having symptoms of Tritiya and Chaturtha Patalgata Timir will be excluded like Kacha and Linganasha. 2. Patient suffering from infectious disease e.g.-viral, bacterial or fungal conjunctivitis, blepharitis and trachoma. 3. Patient having known case of Hypertension, HIV, TB, Rheumatic Heart Disease, Bronchial Asthma, Thyroid disorder. 4. Hypermetropia associated with other ocular disease such as cataract, glaucoma, retinal disease, chorioretinitis, iridocyclitis, choroidal disease, vitreal opacity, cornel opacity, corneal ulcer. 5. Congenital, Acquired non physiological hypermetropia like index hyermetropia, pseudophakic hypermetropia. 6. Refractive errors like astigmatism, myopia, presbyopia and other ocular pathologies will be excluded.

Design outcomes

Primary

MeasureTime frame
A clinical study to evaluate efficacy of Bhaskar Ghrita Nasya and Saptamrita Lauha Vati in Prathama and Dwitiya Patalgata Timir w.r.t Hypermetropia. Parameter of efficacy will be visual acuity before and after treatmentTimepoint: Follow up will betaken on 1st, 11th and 21st day. Parameter of efficacy will be visual acuity before and after treatment

Secondary

MeasureTime frame
A comparison between efficacy of Bhaskar Ghrita Nasya with Saptamrita Lauha and Saptamrita Lauha alone in Prathama and Dwitiya Patalgata Timir w.r.t HypermetropiaTimepoint: Total duration of the study will 18 months.

Countries

India

Contacts

Public ContactDR PRAVIN M BHAT

Sumatibhai Shah Ayurved Mahavidyalaya

vdpravin82@gmail.com09860233173

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026